{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:05:12Z","timestamp":1764828312638},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T00:00:00Z","timestamp":1145404800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Livers of infants with biliary atresia and of neonatal mice infected with rotavirus (RRV) have increased expression of interferon-gamma (IFN\u03b3) and interleukin (IL)-12. While the expression of IFN\u03b3 regulates the obstruction of extrahepatic bile ducts by lymphocytes, the role of IL-12 in the pathogenesis of biliary obstruction is unknown. Based on the role of IL-12 as a key proinflammatory cytokine, we hypothesized that loss of IL-12 prevents the obstruction of extrahepatic bile ducts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>IL12-knockout (IL-12KO) and wild type mice were injected with RRV or saline at day 1 of age and monitored for the development of symptoms. The cellular and molecular phenotypes were determined at days 3, 7, and 14 by real-time PCR and flow cytometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>RRV infection of IL-12KO mice resulted in growth failure, jaundice\/acholic stools, and decreased survival similar to wild-type mice. IL-12KO mice had a remarkable neutrophil-rich portal inflammation and epithelial sloughing of extrahepatic bile ducts. Loss of IL-12 decreased but did not abolish the hepatic expression of IFN\u03b3, displayed a remarkable increase in expression of TNF\u03b1, IFN\u03b1, IFN\u03b2 and decreased expression of IL-4 and IL-5.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Loss of IL-12 did not modify the progression of bile duct obstruction in experimental biliary atresia. However, the inflammatory response was predominantly neutrophil-based and displayed a Th1 response in the absence of IL-12.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-230x-6-14","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T15:47:09Z","timestamp":1145548029000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia"],"prefix":"10.1186","volume":"6","author":[{"given":"Sujit Kumar","family":"Mohanty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranavkumar","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg","family":"Sabla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,4,19]]},"reference":[{"key":"158_CR1","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/hep.510230652","volume":"23","author":"WF Balistreri","year":"1996","unstructured":"Balistreri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman FC, Perlmutter DH, Sokol RJ: Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology. 1996, 23: 1682-1692.","journal-title":"Hepatology"},{"key":"158_CR2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1053\/jhep.2002.34170","volume":"35","author":"DH Perlmutter","year":"2002","unstructured":"Perlmutter DH, Shepherd RW: Extrahepatic biliary atresia: a disease or a phenotype?. Hepatology. 2002, 35: 1297-1304. 10.1053\/jhep.2002.34170.","journal-title":"Hepatology"},{"key":"158_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00005176-200307000-00003","volume":"37","author":"RJ Sokol","year":"2003","unstructured":"Sokol RJ, Mack C, Narkewicz MR, Karrer FM: Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr. 2003, 37: 4-21. 10.1097\/00005176-200307000-00003.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"158_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0168-8278(97)80253-X","volume":"26","author":"U Broome","year":"1997","unstructured":"Broome U, Nemeth A, Hultcrantz R, Scheynius A: Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol. 1997, 26: 857-862. 10.1016\/S0168-8278(97)80253-X.","journal-title":"J Hepatol"},{"key":"158_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1620\/tjem.181.33","volume":"181","author":"PW Dillon","year":"1997","unstructured":"Dillon PW, Belchis D, Minnick K, Tracy T: Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia. Tohoku Journal of Experimental Medicine. 1997, 181: 33-40. 10.1620\/tjem.181.33.","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"158_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/jpsu.2001.24730","volume":"36","author":"M Davenport","year":"2001","unstructured":"Davenport M, Gonde C, Redkar R, Koukoulis G, Tredger M, Mieli-Vergani G, Portmann B, Howard ER: Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg. 2001, 36: 1017-1025. 10.1053\/jpsu.2001.24730.","journal-title":"J Pediatr Surg"},{"key":"158_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1203\/01.PDR.0000130480.51066.FB","volume":"56","author":"CL Mack","year":"2004","unstructured":"Mack CL, Tucker RM, Sokol RJ, Karrer FM, Kotzin BL, Whitington PF, Miller SD: Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res. 2004, 56: 79-87. 10.1203\/01.PDR.0000130480.51066.FB.","journal-title":"Pediatr Res"},{"key":"158_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH793>3.0.CO;2-O","volume":"193","author":"AF Ahmed","year":"2001","unstructured":"Ahmed AF, Ohtani H, Nio M, Funaki N, Shimaoka S, Nagura H, Ohi R: CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis. J Path. 2001, 193: 383-389. 10.1002\/1096-9896(2000)9999:9999<::AID-PATH793>3.0.CO;2-O.","journal-title":"J Path"},{"key":"158_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1172\/JCI200421153","volume":"114","author":"P Shivakumar","year":"2004","unstructured":"Shivakumar P, Campbell KM, Sabla GE, Miethke A, Tiao G, McNeal MM, Ward RL, Bezerra JA: Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest. 2004, 114: 322-329. 10.1172\/JCI200421153.","journal-title":"J Clin Invest"},{"key":"158_CR10","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/S0022-3468(97)90680-1","volume":"32","author":"C Petersen","year":"1997","unstructured":"Petersen C, Biermanns D, Kuske M, Schakel K, Meyer-Junghanel L, Mildenberger H: New aspects in a murine model for extrahepatic biliary atresia. J Ped Surg. 1997, 32: 1190-1195. 10.1016\/S0022-3468(97)90680-1.","journal-title":"J Ped Surg"},{"key":"158_CR11","first-page":"394","volume":"33","author":"M Riepenhoff-Talty","year":"1993","unstructured":"Riepenhoff-Talty M, Schaekel K, Clark HF, Mueller W, Uhnoo I, Rossi T, Fisher J, Ogra PL: Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pedc Res. 1993, 33: 394-399.","journal-title":"Pedc Res"},{"key":"158_CR12","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1126\/science.1074900","volume":"297","author":"KB Nguyen","year":"2002","unstructured":"Nguyen KB, Watford WT, Salomon R, Hofmann SR, Pien GC, Morinobu A, Gadina M, O'Shea JJ, Biron CA: Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science. 2002, 297: 2063-2066. 10.1126\/science.1074900.","journal-title":"Science"},{"key":"158_CR13","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1073\/pnas.90.13.6115","volume":"90","author":"RT Gazzinelli","year":"1993","unstructured":"Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A. 1993, 90: 6115-6119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"158_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1126\/science.8097338","volume":"260","author":"CS Hsieh","year":"1993","unstructured":"Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993, 260: 547-549.","journal-title":"Science"},{"key":"158_CR15","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.154.10.5071","volume":"154","author":"SE Macatonia","year":"1995","unstructured":"Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM, O'Garra A: Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol. 1995, 154: 5071-5079.","journal-title":"J Immunol"},{"key":"158_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1517\/14712598.3.5.715","volume":"3","author":"R Cordoba-Rodriguez","year":"2003","unstructured":"Cordoba-Rodriguez R, Frucht DM: IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics. Expert Opin Biol Ther. 2003, 3: 715-723. 10.1517\/14712598.3.5.715.","journal-title":"Expert Opin Biol Ther"},{"key":"158_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003, 3: 133-146. 10.1038\/nri1001.","journal-title":"Nat Rev Immunol"},{"key":"158_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","volume":"103","author":"CA Dinarello","year":"1999","unstructured":"Dinarello CA: IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol. 1999, 103: 11-24. 10.1016\/S0091-6749(99)70518-X.","journal-title":"J Allergy Clin Immunol"},{"key":"158_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4049\/jimmunol.169.1.323","volume":"169","author":"Y Kinjo","year":"2002","unstructured":"Kinjo Y, Kawakami K, Uezu K, Yara S, Miyagi K, Koguchi Y, Hoshino T, Okamoto M, Kawase Y, Yokota K, Yoshino K, Takeda K, Akira S, Saito A: Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J Immunol. 2002, 169: 323-329.","journal-title":"J Immunol"},{"key":"158_CR20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1084\/jem.189.8.1315","volume":"189","author":"LP Cousens","year":"1999","unstructured":"Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, Ahmed R, Biron CA: Two roads diverged: interferon alpha\/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med. 1999, 189: 1315-1328. 10.1084\/jem.189.8.1315.","journal-title":"J Exp Med"},{"key":"158_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1203\/00006450-199711000-00013","volume":"42","author":"C Petersen","year":"1997","unstructured":"Petersen C, Bruns E, Kuske M, von Wussow P: Treatment of extrahepatic biliary atresia with interferon-alpha in a murine infectious model. Ped Res. 1997, 42: 623-628.","journal-title":"Ped Res"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-6-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-6-14\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-6-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-6-14.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T04:32:05Z","timestamp":1683433925000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-6-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,19]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["158"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-6-14","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,19]]},"assertion":[{"value":"30 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"14"}}